With more than 60,000 study sites in over 60 countries, companies conducting clinical research have relied on OmniComm Systems for more than 20 years to provide technology solutions to better manage complex, international clinical studies. OmniComm has provided full-hosted services, analytics and technology for more than 250 sponsors and CROs involved in Phase I - IV clinical trials in almost every therapeutic class.

Publicly traded, OmniComm Systems has been named to the 2018 OTCQX® Best 50, a ranking of top-performing companies traded on the OTCQX Best Market.

OmniComm operates global headquarters in Fort Lauderdale, FL, and European headquarters in Bonn, Germany, with regional offices in the United States, United Kingdom, Netherlands, Spain, Japan and India.